siRNA-Based Therapy Ameliorates Glomerulonephritis

RNA interference by short interfering RNAs (siRNAs) holds promise as a therapeutic strategy, but use of siRNAs in vivo remains limited. Here, we developed a system to target delivery of siRNAs to glomeruli via poly(ethylene glycol)-poly(l-lysine)-based vehicles. The siRNA/nanocarrier complex was app...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shimizu, Hideki, Hori, Yuichi, Kaname, Shinya, Yamada, Koei, Nishiyama, Nobuhiro, Matsumoto, Satoru, Miyata, Kanjiro, Oba, Makoto, Yamada, Akira, Kataoka, Kazunori, Fujita, Toshiro
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2010
Materias:
Basic Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2844303/
https://ncbi.nlm.nih.gov/pubmed/20203158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009030295
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares